Evasc Neurovascular Enterprises is a medical device company focused on novel solutions for the endovascular repair of cerebral aneurysms. Evasc’s lead product, eCLIPs, is an innovative device designed to treat 95% of cerebral aneurysms and is currently targeted for use in challenging wide-neck bifurcations. eCLIPs effectively treats an aneurysm by bridging the neck, creating flow effect, and providing scaffolding to enable endothelial growth.
Type | Private | |
Founded | 2001 | |
HQ | Vancouver, CA | Map |
Website | evasc.com |
Employees (est.) (Aug 2022) | 24 | (-4%) |
Cybersecurity rating | A | More |
Founding Date | 2001 |
Evasc Neurovascular Enterprises total Funding | $7.6 m |
Evasc Neurovascular Enterprises latest funding size | $7.57 m |
Time since last funding | 5 years ago |
Evasc Neurovascular Enterprises investors | Yonghua Capital |
When was Evasc Neurovascular Enterprises founded?
Evasc Neurovascular Enterprises was founded in 2001.
Who are Evasc Neurovascular Enterprises key executives?
Evasc Neurovascular Enterprises's key executives are Donald Ricci, Scott Wilson and Wieger Kaptein.
How many employees does Evasc Neurovascular Enterprises have?
Evasc Neurovascular Enterprises has 24 employees.
Who are Evasc Neurovascular Enterprises competitors?
Competitors of Evasc Neurovascular Enterprises include Confluent Medical Technologies, Mölnlycke and Welch Allyn.
Where is Evasc Neurovascular Enterprises headquarters?
Evasc Neurovascular Enterprises headquarters is located at 107 W 8th Ave, Vancouver.
Where are Evasc Neurovascular Enterprises offices?
Evasc Neurovascular Enterprises has an office in Vancouver.
How many offices does Evasc Neurovascular Enterprises have?
Evasc Neurovascular Enterprises has 1 office.
Receive alerts for 300+ data fields across thousands of companies